About the Role
You will own the clinical and scientific story end-to-end, deciding which biomarkers and clinical questions the company pursues and shaping the scientific roadmap for years to come. This role is crucial for communicating the company's biological vision to investors, design partners, and clinical collaborators.
Responsibilities
- Develop the scientific narrative, linking biomarkers to clinical decisions for commercial strategies, investor pitches, and grants.
- Cultivate clinical and research partnerships across hematology, oncology, infectious disease, transplant, and translational research.
- Define the assay and panel strategy, including marker selection, clinical rationale, and evidence requirements.
- Oversee clinical evidence generation and trial design, collaborating with regulatory consultants on pathways like pre-submission, CLIA-Waiver/IVDR, and pivotal studies.
- Recruit and chair a Clinical Advisory Board composed of specialists in priority therapy areas.
- Contribute to scientific authorship, including publications and grant submissions, to enhance biological credibility.
- Frame future scientific direction by identifying clinical and translational opportunities that align with the evolving roadmap.
Requirements
- MD, PhD, or DPhil in hematology, immunology, clinical pathology, or cancer immunology.
- 5-10 years of industrial experience as CMO/CSO in diagnostics, cytometry, or cell therapy, or equivalent translational research portfolio with prior spinout experience.
- Proven experience in designing multiparameter immunophenotyping panels and translating them into clinical decisions.
- Deep understanding of how oncologists use CTC counts, hematologists use MRD, and HIV physicians use CD4/CD8 ratios.
- Active clinical practice (1 day/week NHS or honorary contract) is a strong asset.
Skills
- Clinical empathy
- Skepticism of biomarker hype cycles
- Ability to manage fast-paced science and slow, evidence-based regulatory processes
- Intellectual honesty regarding uncertainty
- Direct engagement with clinicians
- Long-term strategic thinking
Location
- London-based
Work Type
- Hybrid
Experience Level
- 5-10 years
Education Level
- MD
- PhD
- DPhil
Salary/Compensations
- Salary set at pre-seed close, calibrated to the round size and market reality
Benefits
- Founding team-level equity
About the Company
- An early-stage deep-tech photonic bio-sensing company combining silicon photonics, micro-fluidics, and applied AI.
- Developing low-cost disposable diagnostic chips and compact readers for point-of-care use.
- First product targets a multi-billion dollar clinical market currently served by expensive, lab-based instruments.
- Mission: To bring clinical-grade diagnostics to the 3.7 billion people lacking access to central laboratory infrastructure.
- Leveraging silicon photonics, AI design, and disposable micro-fluidics to enable rapid, low-cost results at the point of care.
- Focusing on critical clinical applications such as sepsis triage, field CD4/CD8 counts, leukemia screening, and transplant monitoring.
Equal Opportunity
- We are an equal-opportunity employer and value diversity. We consider all applications equally regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity. We strongly encourage individuals from groups traditionally underrepresented in tech to apply.
